Efficacy and tolerability of oral sumatriptan in Indian patients with acute migraine : a multicentre study
Padma, M.V.; Jain, S.; Maheshwari, M.C.; Misra, S.; Karak, B.; Singh, A.K.; Meena, A.K.; Katiyar, C.K.; Tiwari, P.
Neurology India 46(2): 105-108
1998
ISSN/ISBN: 0028-3886 PMID: 29508796 Document Number: 17301
This multicentre, randomized, double-blind, cross over, placebo controlled study evaluated the efficacy and tolerability of oral Sumatriptan (100 mg) in 100 migraineurs. 59 patients completed the study. The results indicate that by 4 hours post-dose62 of patients treated with Sumatriptan achieved relief of headache, compared with 10 of patients treated with placebo. The results show that oral Sumatriptan is an effective drug for treatment of acute migraine in Indian patients, though smaller dosage may be more beneficial.
Document emailed within 1 workday
